Literature DB >> 383616

Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis.

J W Murphy, N Pahlavan.   

Abstract

Previous studies on a cryptococcal culture filtrate (CneF) antigen have shown that the antigen is useful in detecting delayed-type hypersensitivity and that it is specific for Cryptococcus. This study further defined one more parameter of specificity, showing that the CneF antigen does not elicit delayed-type hypersensitivity responses in Cryptococcus albidus-sensitized guinea pigs. When the crude CneF antigen was subjected to ultrafiltration fractionation, the skin test active components were found to be in the 50,000 or greater molecular weight range fraction. The concentrated retentates of the XM50 ultrafiltration membrane were more sensitive antigens than the crude CneF antigens. Further fractionation of the XM50 retentate using 3% acrylamide gel electrophoresis separated the antigen into two bands. One band, the P fraction, migrated only a short distance into the gel; the fraction was carbohydrate-like and did not elicit significant skin test responses in sensitized guinea pigs. The other band, G fraction, appeared with the tracking dye, was glycoprotein-like, and elicited significantly positive skin tests in sensitized guinea pigs. G fractions prepared using three different serotypes of Cryptococcus neoformans elicited similar size indurations when used in skin testing guinea pigs sensitized with either the homologous serotype isolated of C. neoformans or the heterologous serotype isolate.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383616      PMCID: PMC414450          DOI: 10.1128/iai.25.1.284-292.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Glycoprotein staining following electrophoresis on acrylamide gels.

Authors:  R M Zacharius; T E Zell; J H Morrison; J J Woodlock
Journal:  Anal Biochem       Date:  1969-07       Impact factor: 3.365

3.  Acrylamide gel electrophoresis of bacteriophage Q beta: electrophoresis of the intact virions and of the viral proteins.

Authors:  E G Strauss; P Kaesberg
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

4.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

5.  Improved auxanographic method for yeast assimilations: a comparison with other approaches.

Authors:  G A Land; E C Vinton; G B Adcock; J M Hopkins
Journal:  J Clin Microbiol       Date:  1975-09       Impact factor: 5.948

6.  Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis.

Authors:  M A Dykstra; L Friedman
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

7.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

8.  Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans.

Authors:  J W Murphy; J A Gregory; H W Larsh
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

  8 in total
  17 in total

1.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

3.  Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.

Authors:  J W Murphy; F Schafer; A Casadevall; A Adesina
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferate.

Authors:  C H Mody; K L Sims; C J Wood; R M Syme; J C Spurrell; M M Sexton
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans.

Authors:  D Pietrella; R Cherniak; C Strappini; S Perito; P Mosci; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  In vitro binding of natural killer cells to Cryptococcus neoformans targets.

Authors:  N Nabavi; J W Murphy
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

Review 8.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

9.  Immunogenic fractions of Cryptococcus neoformans.

Authors:  J R Graybill; D C Straus; T J Nealon; M Hague; R E Paque
Journal:  Mycopathologia       Date:  1982-04-23       Impact factor: 2.574

10.  Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response.

Authors:  J W Murphy
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.